Form 4 for BLTE BELITE BIO, INC
Accepted 2026-04-13 16:15:08 ET · period of report 2026-04-09 · accession 0001193125-26-152884 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-04-13 16:15 | 2026-04-09 | BLTE | Chen Wan-Shan | Dir | S - Sale | $180.43 | -1,100 | 9,096 | -11% | -$198.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | American depositary share | 2026-04-09 | S | D | 1,100 | $180.43 | 9,096 | D | — | — | (F1) Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. (F2) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/23/2025. |